Skip to main content
Get the Weekly ESG Brief

Myovant Sciences Ltd.

MYOVNYSETrackedESG Rated: 1/2 ProvidersHealth CareBiotechnologySustainalytics: 27.9 · Medium

Market Quote Unavailable · Potential Inactive / Delisted Ticker

Public exchange feeds are not currently returning active trading data for Myovant Sciences Ltd. (MYOV). This company may be delisted, bankrupt, acquired, or halted. To preserve data integrity, prices are never displayed as $0.00. Sourced ESG ratings and sustainability disclosures remain cataloged below.

Coverage
Rated universe Carries an MSCI or Sustainalytics observation.
ESG profile reviewed
Last editorial update to this profile.
Quote
Market data unavailableObservation time is shown beside the price.
Methodology
How we rateProvider ratings are shown separately, never blended.

Market overview

Market data unavailable

Massive Stock Widgets has not returned a current, verifiable snapshot for Myovant Sciences Ltd. (nyse:MYOV). Check again later.

Company Profile & Business Model Overview

Myovant Sciences Ltd. is a leading company in its sector with strong market presence and growth prospects.

Related ESG Peer Equities

Companies in Health Care evaluated across carbon intensity, social metrics, and board governance.

Explore Health Care Peers →

ESG & Sustainability Rating Breakdown

Synthesized multi-provider rating across Environmental, Social, and Corporate Governance dimensions.

Audited Methodology

MSCI ESG Rating

N/A
Sustainalytics Risk Score

27.9

Medium

Data integrity and methodology

MSCI and Sustainalytics ratings are shown separately with their own observation dates; they are not blended into one score, and providers can disagree. Market quotes are delayed or last-close values, and every snapshot states its source and observation time. Read the full rating methodology.

FAQ

Frequently Asked Questions

Direct answers on sustainability scores, risk methodologies, and peer rankings.

What is Myovant Sciences Ltd. (MYOV)'s ESG rating and sustainability score?

Myovant Sciences Ltd. (MYOV) carries a Sustainalytics ESG Risk Score of 27.9, measuring unmanaged corporate ESG risk on a scale of 0 to 50+.

Is Myovant Sciences Ltd. considered an ESG leader or laggard in Health Care?

Independent benchmark status for Myovant Sciences Ltd. is evaluated relative to Health Care peers once third-party coverage publishes official methodology scores.

How does The Impact Investor evaluate ESG stock profiles?

The Impact Investor presents audited third-party ratings from MSCI and Sustainalytics alongside delayed market data and financial fundamentals. We do not blend ratings into proprietary black-box scores, and ratings are never modified by advertising or affiliate relationships.